Industry Roundup: J&J Supreme Court Petition, Ostroff Talks Supplement Regulation
This article was originally published in The Tan Sheet
Supreme Court denies J&J petition in Motrin litigation; FDA chews on latest spiked supplement finding; Ostroff touts supplement market regulation; and more news in brief.
You may also be interested in...
Megan Olsen moves up to general counsel/senior VP, Gretchen Powers to marketing/member experience VP, Haiuyen Nguyen to regulatory/nutrition policy VP and Tammie Betway to office director/executive assistant to president/CEO. CRN also adds Daniel Garza as legislative/legal assistant and Elise Hall as communications assistant.
Johnson & Johnson files a writ of certiorari asking the Supreme Court to review a $140m judgment against the firm in Massachusetts. Questions over “clear evidence” needed for FDA decision to pre-empt state courts are at heart of issue and need the court’s consideration.
Delaware district judge rules against AstraZeneca’s claim the IRA violates its due process rights, echoing findings made by Ohio district judge in Chamber of Commerce’s suit. Only other IRA ruling to date dismissed PhRMA’s complaint on procedural grounds without addressing the merits.